These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17484719)

  • 21. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 22. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 23. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [More than 1 out of 100 will have myocardial infarction and stroke because of enalapril--effect of drug package inserts?].
    Sandström H
    Lakartidningen; 2006 Feb 22-28; 103(8):564, 567; discussion 567. PubMed ID: 16570783
    [No Abstract]   [Full Text] [Related]  

  • 25. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 26. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

  • 27. Secrecy and transparency of medicines licensing in the EU.
    Abraham J; Lewis G
    Lancet; 1998 Aug; 352(9126):480-2. PubMed ID: 9708771
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug counterfeiting burden remains a guess, experts say.
    Traynor K
    Am J Health Syst Pharm; 2009 Jul; 66(14):1246-8. PubMed ID: 19574593
    [No Abstract]   [Full Text] [Related]  

  • 29. Animal, vegetable, mineral: we need to be informed.
    Foss TD
    Br J Nurs; 2005 Oct 13-26; 14(18):951. PubMed ID: 16237346
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation of pharmacoeconomics and outcomes research.
    Radensky P
    Value Health; 2001; 4(1):12-5. PubMed ID: 11704968
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medication directions as a source of technical and scientific information].
    Goncalves Sde A; Melo Gd; Tokarski MH; Barbosa-Branco A
    Rev Saude Publica; 2002 Feb; 36(1):33-9. PubMed ID: 11887227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Information on the composition of chemical preparations for sale on the Belgian market].
    Arch Belg; 1988; 46(7-8):389-95. PubMed ID: 3269207
    [No Abstract]   [Full Text] [Related]  

  • 34. Calls to a Major Teratogen Information Service Regarding Exposures During Breastfeeding.
    Hegedus E; Oakes DJ; Hill M; Ritchie HE; Kennedy DS
    Breastfeed Med; 2019 Nov; 14(9):674-679. PubMed ID: 31368784
    [No Abstract]   [Full Text] [Related]  

  • 35. New (still proposed) rules for sunscreen. UVA testing and ranking may be the most important change.
    Harv Health Lett; 2010 Jun; 35(8):6. PubMed ID: 20700956
    [No Abstract]   [Full Text] [Related]  

  • 36. History in the making: the evolution of consumer product information (CPI).
    Shenfield GM; Tasker JL
    Med J Aust; 1997 Apr; 166(8):425-8. PubMed ID: 9140350
    [No Abstract]   [Full Text] [Related]  

  • 37. Promotional literature: how do we critically appraise?
    Shetty VV; Karve AV
    J Postgrad Med; 2008; 54(3):217-21. PubMed ID: 18626173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open letter on line extensions.
    Krogh C
    Dimens Health Serv; 1990 Nov; 67(8):5. PubMed ID: 2276526
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh.
    Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A
    Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.